Tema Etfs LLC Arcellx, Inc. Transaction History
Tema Etfs LLC
- $1.2 Trillion
- Q3 2025
A detailed history of Tema Etfs LLC transactions in Arcellx, Inc. stock. As of the latest transaction made, Tema Etfs LLC holds 36,809 shares of ACLX stock, worth $3.15 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
36,809
Previous 33,869
8.68%
Holding current value
$3.15 Million
Previous $2.23 Billion
35.5%
% of portfolio
0.25%
Previous 0.59%
Shares
4 transactions
Others Institutions Holding ACLX
# of Institutions
223Shares Held
49.1MCall Options Held
245KPut Options Held
885K-
Paradigm Biocapital Advisors LP New York, NY4.65MShares$398 Million14.29% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.94MShares$338 Million0.0% of portfolio
-
Nea Management Company, LLC Timonium, MD3.75MShares$321 Million20.45% of portfolio
-
Black Rock Inc. New York, NY3.52MShares$301 Million0.0% of portfolio
-
Ra Capital Management, L.P. Boston, MA3.04MShares$260 Million4.37% of portfolio
About Arcellx, Inc.
- Ticker ACLX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 43,819,200
- Market Cap $3.75B
- Description
- Arcellx, Inc., a clinical-stage biotechnology company, engages in the development of various immunotherapies for patients with cancer and other incurable diseases. The company's lead ddCAR product candidate is CART-ddBCMA, which is in phase 1 clinical trial for the treatment of patients with relapsed or refractory (r/r) multiple myeloma (MM). It...